However, it is not clear, or most likely not the case, that any ROS-inducing drug or compound would affect AR/ARv7 protein degradation as well as Enz sensitivity of PCa cells/tissues as the magnitude and specificity of a particular ROS species might play a role in a particular regulation of cellular processes. The gene discussed is AR; the disease is posterior cortical atrophy.